Peter Reinemer

Title: Peter Reinemer: Innovator in Inflammatory Disease Treatment

Introduction

Peter Reinemer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of novel compounds that have the potential to improve therapeutic outcomes for patients suffering from various conditions.

Latest Patents

Peter Reinemer holds a patent for "Clerodane derivatives for modulation of leukotriene receptor activity and related diseases." This patent focuses on the use of extracts comprising special clerodane compounds against inflammatory and allergic diseases. The patent outlines methods for using these compounds in pharmaceutical formulations aimed at treating such conditions. His work emphasizes the importance of these clerodane derivatives in both prophylactic and therapeutic applications.

Career Highlights

Reinemer is currently associated with Biotropics Malaysia Berhad, where he continues to advance his research and development efforts. His career is marked by a commitment to innovation in the pharmaceutical industry, particularly in the area of inflammatory disease treatment.

Collaborations

Peter has collaborated with notable colleagues, including Matthias Gehling and Kathrin Reinhardt. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Peter Reinemer's contributions to the field of pharmaceuticals, particularly through his patent on clerodane derivatives, highlight his role as an innovator in the treatment of inflammatory diseases. His ongoing work at Biotropics Malaysia Berhad continues to pave the way for advancements in this critical area of healthcare.